UCB Pharma (Belgium)
About
In recent decades, authors affiliated with UCB Pharma (Belgium) have published 2.2k papers, which have received a total of 65.1k indexed citations.
Scholars at this organization have produced 507 papers in Molecular Biology, 418 papers in Psychiatry and Mental health and 352 papers in Cellular and Molecular Neuroscience on the topics of Epilepsy research and treatment (371 papers), Pharmacological Effects and Toxicity Studies (285 papers) and Neuroscience and Neuropharmacology Research (275 papers). Their work is cited by papers focused on Molecular Biology (15.6k citations), Psychiatry and Mental health (14.8k citations) and Cellular and Molecular Neuroscience (12.6k citations). Authors at UCB Pharma (Belgium) collaborate with scholars in Belgium, United States and United Kingdom and have published in prestigious journals including Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences. Some of UCB Pharma (Belgium)'s most productive authors include Henrik Klitgaard, Michel Gillard, Armel Stockis, Rafał M. Kamiński and Alain Matagne.
In The Last Decade
Explore institutions with similar magnitude of impact
Breakdown of academic impact, for scholars at Folkhälsans Forskningscentrum Breakdown of academic impact, for scholars at Seoul Institute Breakdown of academic impact, for scholars at University of Applied Sciences Mainz Breakdown of academic impact, for scholars at State Key Laboratory of Synthetic Chemistry Breakdown of academic impact, for scholars at Center for Medical, Agricultural and Veterinary Entomology Breakdown of academic impact, for scholars at Tulane Medical Center Breakdown of academic impact, for scholars at Asklepios Klinik St. Georg Breakdown of academic impact, for scholars at National Center for Advancing Translational Sciences